|
RVNC Revance Therapeutics Inc 1479290 |
| Balance Sheet |
|
Current Assets
|
329,687,000 |
|
Assets
|
461,564,000 |
|
Current Liabilities
|
80,049,000 |
|
Liabilities
|
624,594,000 |
|
Equity
|
-163,030,000 |
|
Shares Out
|
104,181,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-148,157,000 |
|
Investing Cash Flow
|
-15,305,000 |
| Market Analysis |
Market Cap
|
620,394,869 |
|
Price
|
3.68 |
|
BVPS
|
10.92 |
|
PB
|
0.34 |
|
EPS
|
-3.21 |
|
PS
|
2.59 |
|
FCF
|
-163,462,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RVNC documents filed with the SEC.
RVNC Filings
Clear
